Effect of Thyroid Status on Development of Spontaneous Mammary Tumors in Primiparous C3H Mice

Cancer Research

Volumn 42, Issue 11, 1982, Pages 4553-4561

  Vonderhaal, Barbara K ^a   Greco, Antoinette E ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THIOURACIL; THYROXINE;

ANIMAL EXPERIMENT; BREAST; BREAST CANCER; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; HISTOLOGY; HYPERTHYROIDISM; HYPOTHYROIDISM; MOUSE; NONHUMAN;

ANIMAL; FEMALE; HYPERTHYROIDISM; HYPOTHYROIDISM; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; PREGNANCY; PROLACTIN; THYROID GLAND; THYROXINE; TRIIODOTHYRONINE;

EID: 0020443655     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Adami, H. O., Rimsten, A., Thoren, L., Vegelius, J., and Wide, L. Thyroid disease and function in breast cancer patients and non-hospitalized controls evaluated by determination of TSH, T3, rT3 and T4 levels in serum. Acta Chir. Scand., 144:89–97, 1978.
2. Aguino, T. I., and Eskin, B. A. Rat breast structure in altered iodine metabolism. Arch. Pathol., 94: 280–285, 1972.
3. Baker, D. G., and Yaffe, A. H. The influence of thyroid stimulation on the incidence of 3-methylcholanthrene-induced tumors. Cancer Res., 35: 528–530, 1975.
4. Bather, R., and Franks, W. R. Further studies on the role of thyroxine in chemical carcinogenesis. Cancer Res., 12: 247–248, 1952.
5. Bhattacharya, A., and Vonderhaar, B. K. Thyroid hormone regulation of prolactin binding to mouse mammary glands. Biochem. Biophys. Res. Commun., 88: 1405–1411, 1979.
6. Bogardus, G. M., and Finley, J. W. Breast cancer and thyroid disease. Surgery (St. Louis), 49: 461–468, 1961.
7. Cave, W. T. Jr., Dunn, J. T., and MacLeod, R. M. Effects of altered thyroid states on mammary tumor growth and pituitary gland function in rats. J. Natl. Cancer Inst., 59: 993–999, 1977.
8. Chalstrey, L. J., and Benjamin, B. High incidence of breast cancer in thyroid Br. J. Cancer, 20: 670–675, 1966. cancer
9. De Ome, K. B., Faulkin, L. J., Bern, H. A., and Blair, P. B. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H Mice. Cancer Res., 19: 515–520, 1959.
10. De Ome, K. B., Miyamoto, M. J., Osborn, R. C., Guzman, R. C., and Lum, K. Detection of inapparent nodule-transformed cells in the mammary gland tissues of virgin female BALB/cfC3H mice. Cancer Res., 38: 2103–2111, 1978.
11. Dubnik, C. S., Morris, H. P., and Dalton, A. J. Inhibition of mammary-gland development and mammary-tumor formation in female C3H mice following ingestion of thiouracil. J. Natl. Cancer Inst., 10: 815–841, 1950.
12. Dunn, T. B. Morphology of mammary tumors in mice. In: F. Homburger (ed.), The Physiopathology of Cancer, pp. 38–84. New York: Hoeber-Harper, 1959.
13. Edwards, C. R. W., Forsyth, I. A., and Besser, G. M. Amenorrhea, galactorrhea and primary hypothyroidism with high circulating levels of prolactin. Br. Med. J., 3: 462–464, 1971.
14. Eskin, B. A. Iodine metabolism and breast cancer. Trans. N. Y. Acad. Sci., 32:911–947, 1970.
15. Eskin, B. A., Murphey, S. A., and Dunn, M. R. Induction of breast cancer in altered thyroid states. Nature (Lond.), 218: 1162, 1968.
16. Gelato, M., Marshall, S., Boudreau, M., Bruni, J., Campbell, G. A., and Meites, J. Effects of thyroid and ovaries on prolactin binding activity in rat liver. Endocrinology, 96: 1292–1296, 1975.
17. Grice, O. D., Faircloth, S., and Thomas, C. G., Jr. The effect of hypothyroidism on induced cancer of the breast. Proc. Am. Assoc. Cancer Res., 7: 26, 1966.
18. Grice, O. D., Faircloth, S., and Thomas, C. G., Jr. The effect of hypothyroidism of induced cancer of the breast—further observations. Proc. Am. Assoc. Cancer Res., 8: 23, 1967.
19. Gruenstein, H., Meranze, D. R., Acuff, M., and Shimkin, M. B. The role of the thyroid in hydrocarbon-induced mammary carcinogenesis in rats. Cancer Res., 28: 471–474, 1968.
20. Helfenstein, J. E., Young, S., and Currie, A. R. Effect of thiouracil on the development of mammary tumors in rats induced with 9,10-dimethyl-1,2-benzanthracene. Nature (Lond.), 196: 1108, 1962.
21. Hembree, W. C., and Van de Wiele, R. L. Female reproductive system. In: S. C. Werner and S. H. Ingbar (eds.), The Thyroid: A Fundamental and Clinical Text, pp. 757–772. Hagerstown, Md.: Harper and Row, Publishers, Inc., 1978.
22. Hosick, H. L., and Nandi, S. Preliminary survey of hormonal influences on multicellular architecture in primary cultures of mammary carcinoma cells. J. Natl. Cancer Inst., 52: 897–902, 1974.
23. Jull, J. W., and Huggins, C. Influence of hyperthyroidism and of thyroidectomy on induced mammary cancer. Nature (Lond.), 188: 73, 1960.
24. Kapdi, C. C., and Wolfe, J. N. Breast cancer: relationship to thyroid supplements for hypothyroidism. J. Am. Med. Assoc., 236: 1124–1127, 1976.
25. Kellen, J. A. Effect of hypothyroidism on induction of mammary tumors in rats by 7,12-dimethylbenz(a)anthracene. J. Natl. Cancer Inst., 48: 1901–1904, 1972.
26. Knazek, R. A., Liu, S. C., Bodwin, J. S., and Vonderhaar, B. K. Essential fatty acids are required in the diet for development of the mouse mammary gland. J. Natl. Cancer Inst., 64: 377–382, 1980.
27. Leonard, S. L., and Reece, R. P. The relation of the thyroid to mammary gland growth in the rat. Endocrinology, 28: 65–69, 1941.
28. Malarkey, W. B., Schroeder, L. L., Stevens, V. C., James, A. G., and Lanese, R. R. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res., 37: 4655–4659, 1977.
29. McGrath, C. M. Replication of mammary tumor virus in tumor cell cultures: dependence on hormone-induced cellular organization. J. Natl. Cancer Inst., 47: 455–467, 1971.
30. McGuire, W. L., Chamness, G. G., and Costlow, M. E. Hormone dependence in breast cancer. Metab. Clin. Exp., 23: 75–100, 1974.
31. McKenzie, L., Fitzgerald, D. K., and Ebner, K. E. Lactose synthetase activities in rat and mouse mammary glands. Biochim. Biophys. Acta, 230: 526–530, 1971.
32. Meites, J. Relation of prolactin and estrogen to mammary tumorigenesis in the rat. J. Natl. Cancer Inst., 48: 1217–1224, 1972.
33. Mittra, I. Mammotropic effect of prolactin enhanced by thyroidectomy. Nature (Lond.), 248: 525–526, 1974.
34. Mittra, I., and Hayward, J. L. Hypothalamic-pituitary-thyroid axis in breast cancer. Lancet, 1: 885–889, 1974.
35. Moon, R. C., and Turner, C. W. Thyroid hormone and mammary gland growth in the rat. Proc. Soc. Exp. Biol. Med., 103: 149–151, 1960.
36. Moossa, A. R., Evans, D. A., and Brewer, A. C. Thyroid status and breast cancer. Ann. R. Coll. Surg. Eng., 53: 178–188, 1973.
37. Nagasawa, H., Yanai, R., Nakajima, Y., Namiki, H., Kikuyama, S., and Shiota, K. Inhibitory effects of potassium thiocyanate on normal and neo-plastic mammary development in female mice. Eur. J. Cancer, 16:473–480, 1980.
38. Nandi, S., and McGrath, C. M. Mammary neoplasia in mice. Adv. Cancer Res., 17:353–414, 1973.
39. Newman, W. C., and Moon, R. C. Chemically induced mammary cancer in rats with altered thyroid function. Cancer Res., 28: 864–868, 1968.
40. Pearson, O. H., Llerena, O., and Llerena, L. Prolactin-dependent rat mammary cancer: a model for man?. Trans. Assoc. Am. Physicians, 82: 225–238, 1969.
41. Radcliffe, J. D., and Webster, A. J. F. Regulation of food intake during growth in fatty and lean female Zucker rats given diets of different protein content. Br. J. Nutr., 36: 457–469, 1976.
42. Radcliffe, J. D., and Webster, A. J. F. The effect of varying the quality of dietary protein and energy on food intake and growth in the Zucker rat. Br. J. Nutr., 41: 111–124, 1979.
43. Reeve. T. S. Hales, I. B., Rundle, F. F. Myhill, J., and Croydon, M. Thyroid function in the presence of breast cancer. Lancet, 1: 632–633, 1961.
44. Riley, V. Mouse mammary tumors: alteration of incidence as apparent function of stress. Science (Wash. D. C.), 189: 465–467, 1975.
45. Schottenfeld, D. The relationship of breast cancer to thyroid disease. J. Chronic Dis., 21: 303–313, 1968.
46. Sellitti, D. F., Tseng, Y. C. L., and Latham, K. R. Effect of 3,5,3’-triiodo-L-thyronine on the incidence and growth kinetics of spontaneous mammary tumors in C3H/HeN Mice. Cancer Res., 41: 5015–5019, 1981.
47. Shiu, R. P. C., and Friesen, H. G. Prolactin receptors. In: Melvin Blecher (ed.), Methods in Receptor Research, Part 2, pp. 565–598. New York: Marcel Dekker, Inc., 1976.
48. Shoemaker, J. P., Bradley, R. L., and Hoffman, R. V. Increased survival and inhibition of mammary tumors in hypothyroid mice. J. Surg. Res., 21: 151–154, 1976.
49. Shoemaker, J. P., and Dagher, R. K. Remissions of mammary adenocarcinoma in hypothyroid mice given 5-fluorouracil and chloroquine phosphate. J. Natl. Cancer Inst., 62: 1575–1578, 1979.
50. Sicher, K., and Waterhouse, J. A. Thyroid function in relation to mammary cancer. Br. J. Cancer, 15: 45–50, 1961.
51. Singh, D. V., and Bern, H. A. Interaction between prolactin and thyroxine in mouse mammary gland lobulo-alveolar development in vitro. J. Endocrinol.,45: 579–583, 1969.
52. Sirbasku, D. A. Hormone responsive growth in vivo of a tissue culture cell line established from the MT-W9A rat mammary tumor. Cancer Res., 38:1154–1165, 1978.
53. Smith, R. D., Hilf, R., and Senior, A. E. The effect of altered thyroid state on prolactin binding to livers and 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats. Proc. Soc. Exp. Biol. Med., 758. 517–520. 1978.
54. Smithcors. J. F. Effects of thiouracil on the mammary gland. Proc. Soc. Exp. Biol. Med., 59: 197–200, 1945.
55. Sommers, S. C. Endocrine abnormalities in women with breast cancer. Lab. Invest., 4: 160–174, 1955
56. Stoll. B. A. Breast cancer and hypothyroidism. Cancer (Phila.), 78. 1431–1436, 1965.
57. Turkington, R. W., Brew, K., Vanaman, T. C., and Hill, R. L. The hormonalcontrol of lactose synthetase in the developing mouse mammary gland. J. Biol. Chem., 243. 3382–3387. 1968.
58. Vonderhaar, B. K. A role of thyroid hormones in differentiation of mouse mammary gland in vitro. Biochem. Biophys. Res. Commun., 67:1219–1225,1975.
59. Vonderhaar, B. K. Studies on the mechanism by which thyroid hormones enhance a-lactalbumin activity in expiants from mouse mammary glands. Endocrinology, 100: 1423–1431, 1977.
60. Vonderhaar, B. K. Effect of thyroid hormones on mammary tumor induction and growth. In: B. S. Leung (ed.). Hormonal Regulation of Experimental Mammary Tumors. Elmsford, N. Y.: Pergamon Press, Inc., in press, 1982.
61. Vonderhaar, B. K., and Greco, A. E. Labulo-alveolar development of mouse mammary glands is regulated by thyroid hormones. Endocrinology, 704: 409–418, 1979.
62. Welsch, C. W. Prolactin and the development and progression of early neoplastic mammary gland lesions. Cancer Res., 38: 4054–4058, 1978.
63. Welsch, C. W., and Nagasawa, H. Prolactin and murine mammary tumorigenes s: a review. Cancer Res., 37: 951–963, 1977